Latest News
All Times Eastern
- ‘It’s caused a lot of tension in our marriage’: My wife’s family comes visit, hides food and never cleans up. How do we get rid of them?
- Barron's China’s AI Clout Might Be Overstated. What to Know.
- Barron's This Company Makes Costco and Amazon’s Store Brands. Its Stock Is a Buy.
- Barron's This Carbon-Capture Stock Has Big Plans. Why It’s a Buy.
- Barron's Forget Apple and Nvidia. Why June Belongs to Small-Caps.
- Barron's Market Gains as Wall of Worry Crumbles. What Happens Next.
- Judge in FTX bankruptcy rejects media challenge, says customer names can remain secret
- Barron's Commercial Traders Are Net Long Copper. That’s a Good Sign for the Red Metal.
- Mark Zuckerberg says Meta may be ‘primary beneficiary’ of Apple Vision Pro headset
- Biogen stock rallies after full-day halt as FDA panel recommends Alzheimer’s drug for approval
to be replaced
Elevation Oncology Inc.
ELEVUS
$
-0.03
-1.58%
After Hours
$
1.8799
After Hours Volume:
52.18K
| Close | Chg | Chg % |
|---|---|---|
| $1.9100 | -0.9100 | -32.27% |
Volume: 7.93M
65 Day Avg: 2.17M
1.5000
Day Range
2.0700
0.7229
52 Week Range
5.8900
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
ELEV Overview
Key Data
- Open $2.0600
- Day Range 1.5000 - 2.0700
- 52 Week Range 0.7229 - 5.8900
- Market Cap $68.63M
- Shares Outstanding 24.34M
- Public Float 15.72M
- Beta 0.72
- Rev. per Employee N/A
- P/E Ratio N/A
- EPS -$4.0637
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 2.57M 05/31/23
- % of Float Shorted 16.37%
- Average Volume 2.17M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 3
Full Ratings
Recent News
Elevation Oncology downgraded to underweight from neutral at J.P. Morgan
Elevation Oncology downgraded to neutral from overweight at J.P. Morgan
Elevation Oncology stock price target cut to $21 from $27 at Wedbush
Elevation Oncology started at outperform with $27 stock price target at Wedbush
Crude Oil Down Over 1%; Planet Labs PBC Shares Tumble
on Benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
on Benzinga.com
Dow Edges Lower; Sientra Shares Spike Higher
on Benzinga.com
Why Elevation Oncology (ELEV) Stock Is Getting Obliterated
on Benzinga.com
US Stocks Open Higher; Vail Resorts Earnings Miss Views
on Benzinga.com
BBAI Stock Alert: BigBear.ai Announces Direct Offering
on InvestorPlace.com
Why Is Greenlane (GNLN) Stock Down 5% Today?
on InvestorPlace.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
on Benzinga.com
Why Is Elevation Oncology (ELEV) Stock Down 26% Today?
on InvestorPlace.com
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
on InvestorPlace.com
12 Health Care Stocks Moving In Monday's Intraday Session
on Benzinga.com
Short Volatility Alert: Elevation Oncology
on Benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
on Benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
on Benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
on Benzinga.com
Elevation Oncology Blasts Higher on New Cancer Treatment
on TipRanks.com
Elevation Oncology Inc.
Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in New York, NY.